Skip to main content
ACR Convergence 2024 Main banner
Final Program


Schedule at a Glance

  1. Home

  • Saturday, Nov 16th
    9:00 AM – 10:30 AM Eastern Time
    Novel Indications for Hypoglycemic Agents in Rheumatic Diseases: Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists
    Location: Ballroom B
    Moderator: Karen Costenbader, MD, MPH – Brigham and Women's Hospital/ Harvard Medical School
    Moderator: April Jorge, MD – Massachusetts General Hospital
    Epidemiology, health policy and outcomes
     CME 1.5 hours
  • Saturday, Nov 16th
    9:00 AM – 9:30 AM Eastern Time
    SGLT2i and GLP-1 Mechanisms of Action, Uses in Type II DM, Obesity, and the General Population, and Benefits vs. Risks and Side Effects That We May Anticipate in Patients with Rheumatic Diseases
    Location: Ballroom B
    Speaker: LOUIS ARONNE, MD – Weill Cornell Medicine
    Epidemiology, health policy and outcomes
  • Saturday, Nov 16th
    9:30 AM – 10:00 AM Eastern Time
    SGLT2i and GLP-1 Effects on the Heart: Reduction in Heart Failure and Atherosclerotic Coronary Artery Disease
    Location: Ballroom B
    Speaker: Brittany Weber, MD;PhD – Brigham and Women's Hospital
    Epidemiology, health policy and outcomes
  • Saturday, Nov 16th
    10:00 AM – 10:30 AM Eastern Time
    SGLT2i and GLP-1 Effects on the Kidneys: Reduction in Proteinuria and Progression of Renal Failure
    Location: Ballroom B
    Speaker: Isabelle Ayoub, MD – The Ohio State University
    Epidemiology, health policy and outcomes
  • Saturday, Nov 16th
    1:00 PM – 2:30 PM Eastern Time
    FDA Update on Safety Issues in the Treatment of Rheumatic Diseases
    Location: Hall D/E
    Moderator: Michael Weisman, MD – Stanford University
    Epidemiology, health policy and outcomes
     CME 1.5 hours
  • Saturday, Nov 16th
    1:00 PM – 1:30 PM Eastern Time
    Update and Safety Issues on Recently Approved Agents for Rheumatic Diseases
    Location: Hall D/E
    Speaker: Eric Gapud, MD,PhD – U.S. Food and Drug Administration
    Epidemiology, health policy and outcomes
  • Saturday, Nov 16th
    1:30 PM – 2:00 PM Eastern Time
    FDA Issues and Initiatives of Importance to the Rheumatologist
    Location: Hall D/E
    Speaker: Amit Golding, MD,PhD – Food and Drug Administration
    Epidemiology, health policy and outcomes
  • Saturday, Nov 16th
    2:00 PM – 2:30 PM Eastern Time
    Update from the FDA
    Location: Hall D/E
    Speaker: Austin Anderson, DO – FDA
    Epidemiology, health policy and outcomes
  • Sunday, Nov 17th
    10:30 AM – 11:30 AM Eastern Time
    Envisioning a Steroid-Free Future for the Treatment of Rheumatic Diseases
    Location: Room 146AB
    Moderator: Brittany Adler, MD – Johns Hopkins University
    Moderator: Mike Putman, MD,MSc – The Medical College of Wisconsin
    Epidemiology, health policy and outcomes
     CME 1 hours
  • Sunday, Nov 17th
    10:30 AM – 10:50 AM Eastern Time
    Recognize the Evolving Role of Steroids in Management of ANCA-Vasculitis
    Location: Room 146AB
    Speaker: John Stone, MD,MPH – Massachusetts General Hospital , Harvard Medical School
    Epidemiology, health policy and outcomes
  • Sunday, Nov 17th
    10:50 AM – 11:10 AM Eastern Time
    Glucosteroid Stewardship: A Reality in SLE
    Location: Room 146AB
    Speaker: Michelle Petri, MD, MPH – Johns Hopkins University School of Medicine
    Epidemiology, health policy and outcomes
  • Sunday, Nov 17th
    11:10 AM – 11:30 AM Eastern Time
    Developing Personalized Steroid-Free Regimens in Patients With RA and Other ARD
    Location: Room 146AB
    Speaker: Beth Wallace, MD,MS – Michigan Medicine, VA Ann Arbor Healthcare System
    Epidemiology, health policy and outcomes
  • Sunday, Nov 17th
    3:00 PM – 4:30 PM Eastern Time
    When They Grow Up: Med-Peds Rheumatologists' Insights into Caring for Adult Patients with JIA and Childhood-Onset SLE
    Location: Room 201
    Moderator: Emily Brunner, DO,RhMSUS – Geisinger
    Moderator: Rebecca Sadun, MD, PhD – Duke University
    Epidemiology, health policy and outcomes
     CME 1.5 hours
  • Sunday, Nov 17th
    3:00 PM – 3:20 PM Eastern Time
    Childhood-Onset Systemic Lupus Erythematosus in Young Adults: Little People, Big Problems
    Location: Room 201
    Speaker: Cuoghi Edens, MD, FAAP – University of Chicago
    Epidemiology, health policy and outcomes
  • Sunday, Nov 17th
    3:20 PM – 3:40 PM Eastern Time
    Juvenile Idiopathic Arthritis in Adulthood: The
    Location: Room 201
    Speaker: John Bridges, MD,MS – University of Alabama at Birmingham/Children's of Alabama
    Epidemiology, health policy and outcomes
  • Sunday, Nov 17th
    3:40 PM – 4:00 PM Eastern Time
    Lost in Transition: Practical Pearls for Partnering with Young Adults
    Location: Room 201
    Speaker: Sarah D. Bayefsky, MD – Hackensack University Medical Center
    Epidemiology, health policy and outcomes
  • Sunday, Nov 17th
    4:00 PM – 4:30 PM Eastern Time
    Difficult Case Q & A
    Location: Room 201
    Speaker: Cuoghi Edens, MD, FAAP – University of Chicago
    Speaker: John Bridges, MD,MS – University of Alabama at Birmingham/Children's of Alabama
    Speaker: Sarah D. Bayefsky, MD – Hackensack University Medical Center
    Epidemiology, health policy and outcomes
  • Monday, Nov 18th
    9:00 AM – 10:00 AM Eastern Time
    Chasing Zzzs in Rheumatic Disease: Sleep Disorders and Their Impact
    Location: Room 201
    Moderator: Carolyn Smith, MSN;CPNP – Children's of Alabama
    Moderator: Christine Stamatos, DNP,ANP-C – Northwell Health, Division of Rheumatology
    Epidemiology, health policy and outcomes
     CME 1 hours
  • Monday, Nov 18th
    9:00 AM – 9:15 AM Eastern Time
    SLEeping Poorly in SLE—Impacts on Circadian Rhythm and Disease Activity
    Location: Room 201
    Speaker: Alfred Kim, MD, PhD – Washington University School of Medicine, Division of Rheumatology, Department of Medicine
    Epidemiology, health policy and outcomes
  • Monday, Nov 18th
    9:15 AM – 9:30 AM Eastern Time
    Poor Sleep and Disease Activity in RA -- Findings from the RA Sleep Study, RAzzz
    Speaker: Patti Katz, PhD – UCSF
    Epidemiology, health policy and outcomes
  • Monday, Nov 18th
    9:30 AM – 9:45 AM Eastern Time
    Restoring Rest: Strategies for Managing Sleep Disturbances in Patients with Rheumatic Diseases
    Location: Room 201
    Speaker: Yvonne Lee, MD, MMSc – Northwestern University
    Epidemiology, health policy and outcomes
  • Monday, Nov 18th
    9:45 AM – 10:00 AM Eastern Time
    Q & A
    Location: Room 201
    Speaker: Patti Katz, PhD – UCSF
    Speaker: Alfred Kim, MD, PhD – Washington University School of Medicine, Division of Rheumatology, Department of Medicine
    Speaker: Yvonne Lee, MD, MMSc – Northwestern University
    Epidemiology, health policy and outcomes
  • Monday, Nov 18th
    10:30 AM – 11:30 AM Eastern Time
    Biosimilars: Are They Biobetter?
    Location: Ballroom A
    Moderator: Belinda Birnbaum, MD – Bryn Mawr Medical Specialists Association
    Moderator: Jessica Widdifield, PhD – Sunnybrook Research Institute / ICES / UofT Institute of Health Policy, Management & Evaluation
    Epidemiology, health policy and outcomes
     CME 1 hours
  • Monday, Nov 18th
    10:30 AM – 11:30 AM Eastern Time
    Environmental Threats in Rheumatic Disease
    Location: Room 147AB
    Moderator: Candace Feldman, MD, MPH, ScD – Brigham and Women's Hospital
    Moderator: Diane Kamen, MD, MS – Medical University of South Carolina
    Epidemiology, health policy and outcomes
     CME 1 hours
  • Monday, Nov 18th
    10:30 AM – 10:45 AM Eastern Time
    How the Environment Affects Human Health
    Location: Room 147AB
    Speaker: Tamiko Katsumoto, MD – Stanford University
    Epidemiology, health policy and outcomes
  • Monday, Nov 18th
    10:30 AM – 10:50 AM Eastern Time
    A UK Biosimilar Experience of Health Care Utilization and Multiple Switching
    Location: Ballroom A
    Speaker: Kimme Hyrich, MD,PhD – University of Manchester
    Epidemiology, health policy and outcomes
  • Monday, Nov 18th
    10:45 AM – 11:00 AM Eastern Time
    Air Pollution and Rheumatic Disease
    Location: Room 147AB
    Speaker: Sasha Bernatsky, MD,PhD – Research Institute of the McGill University Health Centre
    Epidemiology, health policy and outcomes
  • Monday, Nov 18th
    10:50 AM – 11:10 AM Eastern Time
    Biosimilar: The Canadian Experience
    Location: Ballroom A
    Speaker: Diane Lacaille, MD, FRCPC – Arthritis Research Canada, University of British Columbia
    Epidemiology, health policy and outcomes
  • Monday, Nov 18th
    11:00 AM – 11:15 AM Eastern Time
    What Can Be Done to Change the Environmental Problems with Health?
    Location: Room 147AB
    Speaker: Paul Dellaripa, MD – Brigham and Womens Hospital
    Epidemiology, health policy and outcomes
  • Monday, Nov 18th
    11:00 AM – 11:30 AM Eastern Time
    Panel Discussion
    Location: Room 147AB
    Panelist: Paul Dellaripa, MD – Brigham and Womens Hospital
    Panelist: Tamiko Katsumoto, MD – Stanford University
    Panelist: Sasha Bernatsky, MD,PhD – Research Institute of the McGill University Health Centre
    Epidemiology, health policy and outcomes
  • Monday, Nov 18th
    11:10 AM – 11:30 AM Eastern Time
    The USA Perspective on Biosimilars in Routine Care
    Location: Ballroom A
    Speaker: Jonathan Kay, MD – Division of Rheumatology, Department of Medicine, UMass Chan Medical School and UMass Memorial Medical Center
    Epidemiology, health policy and outcomes
  • Monday, Nov 18th
    1:00 PM – 2:30 PM Eastern Time
    Rheumatoid Arthritis Panel Discussion: Treating Rheumatoid Arthritis Patients with Complicated Comorbid Conditions
    Location: Hall D/E
    Moderator: Maria I. ("Maio") Danila, MD,MSc,MPH – University of Alabama at Birmingham (UAB), Birmingham VA Medical Center
    Moderator: Elena Myasoedova, MD;PhD – Mayo Clinic
    Epidemiology, health policy and outcomes
     CME 1.5 hours
  • Monday, Nov 18th
    1:40 PM – 2:00 PM Eastern Time
    Optimal Management of Patients with Rheumatoid Arthritis and Liver Disease
    Location: Hall D/E
    Speaker: Arthur Kavanaugh, MD – UCSD
    Epidemiology, health policy and outcomes